Parcel delivery rates: What 2025 could bring FedEx, UPS shippers
Delivery discounts persist, but experts say lightweight and heavier packages are vulnerable to pricing pressure this year.
Registered Outsourcing Facilities
Discover FDA’s comprehensive list of registered outsourcing facilities engaged in human drug compounding. Get the latest updates, compliance guidelines, and…
PDUFA Performance Reports
PDUFA Performance Reports
Nearly 3 in 4 workers say they can only meet their basic living expenses
Salaries not keeping up with inflation is one culprit of employees’ financial stress, according to a Resume Now report.
Ericsson touts ‘broad-based production’ as tariff deterrent
The telecommunications company invested $50 million in its U.S. factory over the last two years as it navigates a shifting…
Industry Information and Guidance
FDA review of biosimilar and interchangeable products requires a 351(k) biologics license application that includes information demonstrating biosimilarity.
Biosimilars | Science and Research
Learn about FDA’s latest in biosimilar science and research.
BsUFA III Regulatory Science Pilot Program: Progress Update – 01/22/2025
BsUFA III Regulatory Science Pilot Program: Progress Update
ProRx, LLC – 696742 – 12/20/2024
Compounding Pharmacy/Adulterated Drug Products
Kardesler Ucan Yaglar Sanayi Anonim Sirketi – 695413 – 01/21/2025
CGMP/Finished Pharmaceutical/Adulterated